Literature DB >> 3242546

Demonstration of glycosylation variants of human fibrinogen, using the new technique of glycoprotein lectin immunosorbent assay (GLIA).

E Köttgen1, B Hell, C Müller, R Tauber.   

Abstract

A new highly sensitive method, incorporation the ELISA technique (enzyme-linked immunosorbent assay), is described for the quantitation of the glycan residues of glycoproteins. With the aid of this "glycoprotein-lectin immunosorbent assay (GLIA)", it is possible to determine the nature of the glycan residues of a single protein in a glycoprotein mixture, without prior purification. The GLIA can be used for the accurate determination of the inhibitor constant for the interaction of any monosaccharide with any lectin. Using the described technique, glycosylation of human fibrinogen from plasma and amniotic fluid were compared. In fibrinogen from amniotic fluid a "fetal" glycosylation type could be demonstrated. In addition, evidence is presented for the first time that plasma fibrinogen possesses (GlcNAc beta 1----4Man beta) residues (bisecting GlcNAc) and O-glycosidically bound carbohydrate units. Preliminary results were published as abstract (E. Köttgen et al. (1988) Fresenius Z. Anal. Chem. 330, 448).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242546     DOI: 10.1515/bchm3.1988.369.2.1157

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  2 in total

1.  Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated.

Authors:  A F Swanson; C C Kuo
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Use of porcine fibrinogen as a model glycoprotein to study the binding specificity of the three variants of K88 lectin.

Authors:  C L'Hôte; S Berger; S Bourgerie; Y Duval-Iflah; R Julien; Y Karamanos
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.